HOOKIPA Pharma News - HOOK

Company Name	Stock Ticker Symbol	Market	Type
HOOKIPA Pharma Inc	HOOK	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0939	11.65%	0.90	19:57:47

Open Price	Low Price	High Price	Close Price	Prev Close
0.795	0.7787	0.9489	0.8933	0.8061

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	07:01	GLOBE	HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for..
4/24/2024	07:01	GLOBE	HOOKIPA Pharma Announces FDA Clearance of its..
4/16/2024	16:30	GLOBE	HOOKIPA Pharma Announces Grant of Inducement Award Under..
4/10/2024	07:01	GLOBE	HOOKIPA Pharma to Host Investor Call on HB-200 and Planned..
3/22/2024	07:01	GLOBE	HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023..
3/06/2024	07:01	GLOBE	HOOKIPA Pharma to Participate in Leerink Partners Global..
1/31/2024	16:30	EDGAR2	Form 8-K - Current report
1/29/2024	08:12	EDGAR2	Form 8-K - Current report
1/29/2024	08:01	GLOBE	HOOKIPA Pharma Provides Update on Business Priorities and..
1/16/2024	07:01	GLOBE	HOOKIPA Pharma Appoints Mark Winderlich as Chief Development..
1/05/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
12/22/2023	07:33	EDGAR2	Form S-3 - Registration statement under Securities Act of..
12/21/2023	07:06	EDGAR2	Form 8-K - Current report
12/21/2023	07:01	GLOBE	HOOKIPA Pharma Announces $21.25 Million Equity Investment..
12/01/2023	16:46	EDGAR2	Form 8-K - Current report
11/20/2023	07:01	GLOBE	HOOKIPA Pharma Announces FDA Clearance of its..
11/09/2023	07:10	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/2023	07:05	EDGAR2	Form 8-K - Current report
11/09/2023	07:01	GLOBE	HOOKIPA Pharma Reports Third Quarter 2023 Financial..
11/03/2023	12:01	GLOBE	HOOKIPA Pharma Presents Positive Biomarker and Translational..
11/02/2023	16:01	GLOBE	HOOKIPA Pharma to Report Third Quarter 2023 Financial..
10/22/2023	06:01	GLOBE	HOOKIPA Pharma Presents Additional Preliminary Phase 2 Data..
10/20/2023	16:05	EDGAR2	Form 8-K - Current report
10/18/2023	07:01	GLOBE	HOOKIPA Pharma announces publication of preclinical data of..
9/13/2023	08:47	EDGAR2	Form 8-K - Current report
9/13/2023	08:45	GLOBE	HOOKIPA Announces Executive Leadership Change
9/12/2023	08:01	EDGAR2	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
9/12/2023	07:01	GLOBE	HOOKIPA Announces Grant of Inducement Awards Under Nasdaq..
9/06/2023	07:01	GLOBE	HOOKIPA Pharma to participate in upcoming investor..
8/22/2023	16:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/17/2023	16:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/10/2023	16:13	EDGAR2	Form SC TO-I - Tender offer statement by Issuer
8/10/2023	07:07	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/2023	07:05	EDGAR2	Form 8-K - Current report
8/10/2023	07:01	GLOBE	HOOKIPA Pharma Reports Second Quarter 2023 Financial Results..
8/04/2023	16:10	EDGAR2	Form 8-K - Current report
8/03/2023	07:01	GLOBE	HOOKIPA Pharma to Report Second Quarter 2023 Financial..
7/03/2023	16:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
6/10/2023	05:00	GLOBE	HOOKIPA Announces Grant of Inducement Awards Under Nasdaq..
5/31/2023	21:30	GLOBE	HOOKIPA Pharma Announces Pricing of $50.0 Million Public..
5/31/2023	16:45	GLOBE	HOOKIPA Pharma Announces Positive Preliminary Phase 2 Data..
5/11/2023	07:01	GLOBE	HOOKIPA Pharma Reports First Quarter 2023 Financial..
5/09/2023	07:01	GLOBE	HOOKIPA Announces First Person Dosed in Phase 1a/b Clinical..
5/04/2023	07:02	GLOBE	HOOKIPA Pharma to Participate in Upcoming Investor..
5/04/2023	07:01	GLOBE	HOOKIPA Pharma to Report First Quarter 2023 Financial..